Neonatal spongioform myelinopathy after restricted application of hexachlorophane skin disinfectant.
Open Access
- 1 January 1981
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 34 (1) , 25-29
- https://doi.org/10.1136/jcp.34.1.25
Abstract
At least four out of 97 low birth weight (less than 1750 g) newborn infants who had received only limited skin disinfection with 3% hexachlorophane (HCP) emulsion developed spongioform myelinopathy in association with detectable amounts of HCP in their brains. These four cases were found in a post-mortem survey of 20 out of the 27 infants who died. Another nine of these infants had detectable amounts of HCP in the brain but no myelinopathy. It is at present not possible to define a 'safe" level of exposure to 3% HCP emulsion for small preterm infants in the first 2 weeks of life.Keywords
This publication has 12 references indexed in Scilit:
- Acute hexachlorophene poisoning by mouth in a neonateThe Journal of Pediatrics, 1979
- Clinical pharmacology of hexachlorophene in newborn infantsThe Journal of Pediatrics, 1977
- Hexachlorophene Lesions in Newborn InfantsArchives of Pediatrics & Adolescent Medicine, 1976
- Neurotoxicity of Hexachlorophene in HumansArchives of Neurology, 1975
- Spongioform myelinopathy in premature infants.BMJ, 1975
- Hexachlorophene myelinopathy in premature infantsPublished by Elsevier ,1973
- Hexachlorophene encephalopathyActa Neuropathologica, 1973
- Hexachlorophene Effects on the Rat BrainArchives of environmental health, 1971
- Spongy degeneration in the white matter of the central nervous system in the newborn: pathological findings in three infants, one with hyperglycinaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1969
- EFFECT OF HEXACHLOROPHANE ON INCIDENCE OF STAPHYLOCOCCAL AND GRAM-NEGATIVE INFECTION IN THE NEWBORNThe Lancet, 1968